ProCE Banner Activity

My Thoughts on Assessing HBV Treatment Candidacy in the Setting of Other Host Factors

Clinical Thought
The role of host factors in the monitoring and treatment of chronic hepatitis B is an area largely unexplored by the guidelines. Here’s my approach to assessing patients for treatment candidacy in the setting of other host factors.

Released: August 26, 2021

Expiration: August 25, 2022

Share

Faculty

Maria Buti

Maria Buti, MD

Professor of Medicine
Senior Consultant
Hospital Universitario Valle Hebron
Barcelona, Spain

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from:

Gilead Sciences, Inc.

Faculty Disclosure

Primary Author

Maria Buti, MD

Professor of Medicine
Senior Consultant
Hospital Universitario Valle Hebron
Barcelona, Spain

Maria Buti, MD, has disclosed that she has received consulting fees from AbbVie, Gilead Sciences, GlaxoSmithKline, Immunocore, Janssen, MSD, Roche, and Spring Bank.